Literature DB >> 25896504

Salicylate inhibits thrombopoiesis in rat megakaryocytes by changing the membrane micro-architecture.

Itsuro Kazama1, Asuka Baba, Yasuhiro Endo, Hiroaki Toyama, Yutaka Ejima, Mitsunobu Matsubara, Masahiro Tachi.   

Abstract

BACKGROUND/AIMS: Salicylate causes drug-induced immune thrombocytopenia. However, some clinical studies indicate the presence of additional mechanisms in the drug-induced thrombocytopenia, by which the platelet production from megakaryocytes may directly be affected. Since salicylate is amphiphilic and preferentially partitioned into the lipid bilayers of the plasma membrane, it can induce some structural changes in the megakaryocyte membrane surface and thus affect the process of thrombopoiesis.
METHODS: Employing the standard patch-clamp whole-cell recording technique, we examined the effects of salicylate on the membrane capacitance in rat megakaryocytes. Taking electron microscopic imaging of the cellular surface, we also examined the effects of salicylate on the membrane micro-architecture of megakaryocytes.
RESULTS: Salicylate significantly decreased the membrane capacitance of megakaryocytes, indicating the decreased number of invaginated plasma membranes, which was not detected by the fluorescent imaging technique. As shown by electron microscopy, salicylate actually halted the process of pro-platelet formation in megakaryocytes.
CONCLUSION: This study demonstrated for the first time that salicylate inhibits the process of thrombopoiesis in megakaryocytes, as detected by the decrease in the membrane capacitance. Salicylate-induced changes in the membrane micro-architecture are thought to be responsible for its effects.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896504     DOI: 10.1159/000374039

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

1.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

2.  Associations of Gut Microbiota and Fatty Metabolism With Immune Thrombocytopenia.

Authors:  Xiaomin Yu; Qingyun Zheng; Yun He; Dandan Yu; Guolin Chang; Cheng Chen; Laixi Bi; Jia Lv; Misheng Zhao; Xiangyang Lin; Liqing Zhu
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment.

Authors:  Xi Zhang; Xiaolin Zhang; Fangnian Tong; Yi Cai; Yujie Zhang; Haixu Song; Xiaoxiang Tian; Chenghui Yan; Yaling Han
Journal:  Elife       Date:  2022-03-08       Impact factor: 8.140

4.  Delayed Rectifier K+-Channel Is a Novel Therapeutic Target for Interstitial Renal Fibrosis in Rats with Unilateral Ureteral Obstruction.

Authors:  Nozomu Abe; Hiroaki Toyama; Kazutomo Saito; Yutaka Ejima; Masanori Yamauchi; Hajime Mushiake; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2019-11-07       Impact factor: 3.411

5.  α 1-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells.

Authors:  Nozomu Abe; Hiroaki Toyama; Yutaka Ejima; Kazutomo Saito; Tsutomu Tamada; Masanori Yamauchi; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2020-05-12       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.